These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 33263761)
61. Memory impairment and Alzheimer's disease pathology in individuals with MCI who underestimate or overestimate their decline. Bregman N; Kavé G; Zeltzer E; Biran I; Int J Geriatr Psychiatry; 2020 May; 35(5):581-588. PubMed ID: 32011757 [TBL] [Abstract][Full Text] [Related]
62. Interaction between memory impairment and depressive symptoms can exacerbate anosognosia: a comparison of Alzheimer's disease with mild cognitive impairment. Oba H; Matsuoka T; Imai A; Fujimoto H; Kato Y; Shibata K; Nakamura K; Narumoto J Aging Ment Health; 2019 May; 23(5):595-601. PubMed ID: 29528693 [TBL] [Abstract][Full Text] [Related]
63. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene. Aguirre-Acevedo DC; Jaimes-Barragán F; Henao E; Tirado V; Muñoz C; Reiman EM; Tariot PN; Langbaum JB; Lopera F Int Psychogeriatr; 2016 Mar; 28(3):503-10. PubMed ID: 26478578 [TBL] [Abstract][Full Text] [Related]
64. Investigation of triggering receptor expressed on myeloid cells 2 variant in the Wisconsin Registry for Alzheimer's Prevention. Engelman CD; Koscik RL; Jonaitis EM; Hermann BP; La Rue A; Sager MA Neurobiol Aging; 2014 Jun; 35(6):1252-4. PubMed ID: 24378087 [TBL] [Abstract][Full Text] [Related]
66. The effect of rare variants in TREM2 and PLD3 on longitudinal cognitive function in the Wisconsin Registry for Alzheimer's Prevention. Engelman CD; Darst BF; Bilgel M; Vasiljevic E; Koscik RL; Jedynak BM; Johnson SC Neurobiol Aging; 2018 Jun; 66():177.e1-177.e5. PubMed ID: 29395285 [TBL] [Abstract][Full Text] [Related]
67. Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN). Storandt M; Balota DA; Aschenbrenner AJ; Morris JC Neuropsychology; 2014 Jan; 28(1):19-29. PubMed ID: 24219606 [TBL] [Abstract][Full Text] [Related]
68. Behavioral and Electrophysiological Correlates of Memory Binding Deficits in Patients at Different Risk Levels for Alzheimer's Disease. Pietto M; Parra MA; Trujillo N; Flores F; García AM; Bustin J; Richly P; Manes F; Lopera F; Ibáñez A; Baez S J Alzheimers Dis; 2016 Jun; 53(4):1325-40. PubMed ID: 27372640 [TBL] [Abstract][Full Text] [Related]
69. The Value of Pre-Screening in the Alzheimer's Prevention Initiative (API) Autosomal Dominant Alzheimer's Disease Trial. Rios-Romenets S; Giraldo-Chica M; López H; Piedrahita F; Ramos C; Acosta-Baena N; Muñoz C; Ospina P; Tobón C; Cho W; Ward M; Langbaum JB; Tariot PN; Reiman EM; Lopera F J Prev Alzheimers Dis; 2018; 5(1):49-54. PubMed ID: 29405233 [TBL] [Abstract][Full Text] [Related]
70. Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging. Vannini P; Hanseeuw B; Munro CE; Amariglio RE; Marshall GA; Rentz DM; Pascual-Leone A; Johnson KA; Sperling RA Neuroimage Clin; 2017; 15():408-414. PubMed ID: 28616381 [TBL] [Abstract][Full Text] [Related]
76. Phenotypic profile of early-onset familial Alzheimer's disease caused by presenilin-1 E280A mutation. Sepulveda-Falla D; Glatzel M; Lopera F J Alzheimers Dis; 2012; 32(1):1-12. PubMed ID: 22766738 [TBL] [Abstract][Full Text] [Related]
77. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study. Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133 [TBL] [Abstract][Full Text] [Related]
78. Antecedents and consequences of unawareness of memory impairment in dementia. Wilson RS; Barnes LL; Rajan KB; Boyle PA; Sytsma J; Weuve J; Evans DA Neuropsychology; 2018 Nov; 32(8):931-940. PubMed ID: 30047756 [TBL] [Abstract][Full Text] [Related]
79. Unawareness of cognitive deficit (cognitive anosognosia) in probable AD and control subjects. Barrett AM; Eslinger PJ; Ballentine NH; Heilman KM Neurology; 2005 Feb; 64(4):693-9. PubMed ID: 15728294 [TBL] [Abstract][Full Text] [Related]
80. Cognitive and functional neuroimaging correlate for anosognosia in mild cognitive impairment and Alzheimer's disease. Vogel A; Hasselbalch SG; Gade A; Ziebell M; Waldemar G Int J Geriatr Psychiatry; 2005 Mar; 20(3):238-46. PubMed ID: 15717342 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]